Skip to main content
FinSpry Logo
FinSpry
KEX logo
KEX
(NYSE)
Kirby Corporation
$138.23-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kirby Corporation (KEX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Kirby Corporation stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Strong Buy
Based on 5 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$160.00
↑ 15.75% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest KEX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ken Hoexter
BofA Securities
BuyReiterates
$169.00
Jonathan Chappell
Evercore ISI Group
BuyMaintains
$138.00 → $158.00
Gregory Lewis
BTIG
Strong BuyMaintains
$135.00 → $160.00
Ben Mohr
Citi
Strong BuyMaintains
$147.00 → $160.00
Scott Group
Wolfe Research
BuyMaintains
$136.00 → $153.00

Frequently Asked Questions

What is the analyst consensus rating for KEX?

The analyst consensus rating for KEX is "Strong Buy" based on 5 analyst recommendations.

What is the average price target for KEX?

The average 12-month price target for KEX is $160.00, representing an upside of 15.7% from the current price of $138.23.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.